BJDX
Income statement / Annual
Last year (2023), Bluejay Diagnostics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Bluejay Diagnostics, Inc.'s net income was -$9.95 M.
See Bluejay Diagnostics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$249,040.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$780,955.00 |
$200,129.00 |
$145,719.00 |
$157,039.00 |
$142,975.00 |
| Gross Profit |
-$780,955.00 |
$48,911.00 |
-$145,719.00 |
-$157,039.00 |
-$142,975.00 |
| Gross Profit Ratio |
0 |
0.2 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.71 M
|
$4.15 M
|
$1.15 M
|
$527,253.00
|
$454,610.00
|
| General & Administrative
Expenses |
$4.31 M
|
$4.76 M
|
$1.79 M
|
$596,116.00
|
$883,999.00
|
| Selling & Marketing
Expenses |
$283,443.00
|
$451,421.00
|
$289,726.00
|
$73,022.00
|
$292,804.00
|
| Selling, General &
Administrative Expenses |
$4.60 M
|
$5.21 M
|
$2.08 M
|
$669,138.00
|
$1.18 M
|
| Other Expenses |
$0.00 |
$258,137.00 |
-$75,000.00 |
$5,537.00 |
$749,445.00 |
| Operating Expenses |
$10.31 M |
$9.37 M |
$3.16 M |
$1.20 M |
$1.63 M |
| Cost And Expenses |
$10.31 M |
$9.57 M |
$3.16 M |
$1.20 M |
$1.63 M |
| Interest Income |
$164,900.00 |
$89,673.00 |
$513,296.00 |
$143,667.00 |
$52,284.00 |
| Interest Expense |
$0.00 |
$0.00 |
$367,459.00 |
$26,997.00 |
$0.00 |
| Depreciation &
Amortization |
$780,955.00
|
$306,368.00
|
$145,719.00
|
$157,039.00
|
$142,975.00
|
| EBITDA |
-$9.17 M
|
-$8.99 M
|
-$3.08 M
|
-$1.04 M
|
-$1.49 M
|
| EBITDA Ratio |
0 |
-36.38 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
-37.41
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$357,328.00
|
$20,828.00
|
-$258,135.00
|
$38,106.00
|
$811,571.00
|
| Income Before Tax |
-$9.95 M |
-$9.30 M |
-$3.49 M |
-$1.16 M |
-$819,842.00 |
| Income Before Tax Ratio
|
0
|
-37.33
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$69,059.00 |
$241,388.00 |
-$32,569.00 |
-$62,126.00 |
| Net Income |
-$9.95 M |
-$9.23 M |
-$3.73 M |
-$1.13 M |
-$757,716.00 |
| Net Income Ratio |
0 |
-37.05 |
0 |
0 |
0 |
| EPS |
-72.62 |
-73.22 |
-29.67 |
-14.19 |
-9.55 |
| EPS Diluted |
-72.62 |
-73.22 |
-29.67 |
-14.19 |
-9.55 |
| Weighted Average Shares
Out |
$137,062.00
|
$126,024.00
|
$125,701.00
|
$79,339.00
|
$79,339.00
|
| Weighted Average Shares
Out Diluted |
$137,063.00
|
$126,024.00
|
$125,701.00
|
$79,339.00
|
$79,339.00
|
| Link |
|
|
|
|
|
